NCT04146961View on ClinicalTrials.gov

The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

October 5, 2019

Primary Completion Date

April 10, 2020

Study Completion Date

July 21, 2020

Conditions
Cataract Surgery
Interventions
DEVICE

Alcon PanOptix or PanOptix Toric IOL

Patients who previously underwent cataract surgery with the Alcon PanOptix or PanOptix Toric IOL in both eyes.

Trial Locations (3)

92653

Harvard Eye Associates, Laguna Hills

34990-1913

Quentin Allen, Palm City

62025-3886

Quantum Vision Center, Edwardsville

All Listed Sponsors
lead

Research Insight LLC

INDUSTRY

NCT04146961 - The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance | Biotech Hunter | Biotech Hunter